SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes

Posted In GLOMERULAR DISEASES, Diabetic nephropathy, NEPHROLOGY, glomerular diseases

PeerView CME

Course Director, Dr. John Buse, MD
chief, division of endocrinology
Univ of north carolina, chapel hill, NC

You must be logged in to post a comment.

WELCOME TO RENAL MEDCASE – A KIDNEYTUBE CHANNEL MEMBER